Evidence map›Paper›PMID 38247817›Full record

ArticleCells2024

Coronavirus M Protein Trafficking in Epithelial Cells Utilizes a Myosin Vb Splice Variant and Rab10.

Lynne A Lapierre, Joseph T Roland, Elizabeth H Manning, Catherine Caldwell, Honor L Glenn, Pierre-Olivier Vidalain, Frederic Tangy, Brenda G Hogue, C A M de Haan, James R Goldenring

Open access · goldAbstract read
In one paragraph

Article in Cells, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.2field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 5 institutions in 3 countries.

Lynne A LapierreDepartment of Surgery, Vanderbilt University School of Medicine, Nashville, TN 37232, USA.ORCID 0000-0002-7163-0830
Joseph T RolandDepartment of Surgery, Vanderbilt University School of Medicine, Nashville, TN 37232, USA.
Elizabeth H ManningDepartment of Surgery, Vanderbilt University School of Medicine, Nashville, TN 37232, USA.
Catherine CaldwellDepartment of Surgery, Vanderbilt University School of Medicine, Nashville, TN 37232, USA.
Honor L GlennBiodesign Institute Center for Immunotherapy, Vaccines & Virotherapy, Tempe, AZ 85287, USA.
Pierre-Olivier VidalainEquipe Infections Virales, Métabolisme et Immunité, Centre International de Recherche en Infectiologie (CIRI), Univ. Lyon, INSERM U1111, CNRS UMR5308, Ecole Normale Supérieure de Lyon, Université Claude Bernard Lyon 1, 69008 Lyon, France.
Frederic TangyViral Genomics and Vaccination Unit, Department of Virology, Institut Pasteur, CNRS UMR3569, 75015 Paris, France.ORCID 0000-0002-5937-5654
Brenda G HogueBiodesign Institute Center for Immunotherapy, Vaccines & Virotherapy, Tempe, AZ 85287, USA.ORCID 0000-0002-4545-9208
C A M de HaanFaculty of Veterinary Medicine, Department of Biomolecular Health Sciences, Division of Infectious Diseases and Immunology, Section Virology, University of Utrecht, 3584 CS Utrecht, The Netherlands.ORCID 0000-0002-4459-9874
James R GoldenringDepartment of Surgery, Vanderbilt University School of Medicine, Nashville, TN 37232, USA.ORCID 0000-0002-7833-2940
Vanderbilt University · USArizona State University · USCentre National de la Recherche Scientifique · FRUniversité Claude Bernard Lyon 1 · FRUtrecht University · NL

Funding

Tumor Immunology and Microenvironment Research ProgramP30CA068485 · NCI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI STACIE B DUSETZINA · 1995 to 2026
$172.8M
Translational Analysis CoreP30DK058404 · NIDDK · VANDERBILT UNIVERSITY MEDICAL CENTER · PI RICHARD M. PEEK · 2002 to 2026
$29.9M
Vanderbilt Diabetes Research CenterP30DK020593 · NIDDK · VANDERBILT UNIVERSITY MEDICAL CENTER · PI ALVIN C POWERS · 2012 to 2026
$29.3M
Shop Module CoreP30EY008126 · NEI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI David J. Calkins · 1989 to 2026
$19.6M
Vanderbilt Mouse Metabolic Physiology CenterU24DK059637 · NIDDK · VANDERBILT UNIVERSITY · PI WASSERMAN, DAVID H · 2001 to 2015
$14.9M
COngenital Diarrhea and Enteropathy (PediCODE) Consortium and BioRepositoryRC2DK118640 · NIDDK · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI James Richard Goldenring, Izumi Kaji · 2019 to 2026
$14.8M
SMALL GTP BINDING PROTEINS IN GASTROINTESTINAL MUCOSAR01DK048370 · NIDDK · VANDERBILT UNIVERSITY MEDICAL CENTER · PI GOLDENRING, JAMES RICHARD · 1994 to 2025
$10.1M
NCI NIH HHS P30 CA068485NEI NIH HHS P30 EY008126NIDDK NIH HHS P30 DK020593NIDDK NIH HHS P30 DK058404NIDDK NIH HHS R01 DK048370NIDDK NIH HHS RC2 DK118640NIDDK NIH HHS U24 DK059637NIH HHS R01 DK48370
6 · The paper itself

Abstract

The membrane (M) glycoprotein of coronaviruses (CoVs) serves as the nidus for virion assembly. Using a yeast two-hybrid screen, we identified the interaction of the cytosolic tail of Murine Hepatitis Virus (MHV-CoV) M protein with Myosin Vb (MYO5B), specifically with the alternative splice variant of cellular MYO5B including exon D (MYO5B+D), which mediates interaction with Rab10. When co-expressed in human lung epithelial A549 and canine kidney epithelial MDCK cells, MYO5B+D co-localized with the MHV-CoV M protein, as well as with the M proteins from Porcine Epidemic Diarrhea Virus (PEDV-CoV), Middle East Respiratory Syndrome (MERS-CoV) and Severe Acute Respiratory Syndrome 2 (SARS-CoV-2). Co-expressed M proteins and MYO5B+D co-localized with endogenous Rab10 and Rab11a. We identified point mutations in MHV-CoV M that blocked the interaction with MYO5B+D in yeast 2-hybrid assays. One of these point mutations (E121K) was previously shown to block MHV-CoV virion assembly and its interaction with MYO5B+D. The E to K mutation at homologous positions in PEDV-CoV, MERS-CoV and SARS-CoV-2 M proteins also blocked colocalization with MYO5B+D. The knockdown of Rab10 blocked the co-localization of M proteins with MYO5B+D and was rescued by re-expression of CFP-Rab10. Our results suggest that CoV M proteins traffic through Rab10-containing systems, in association with MYO5B+D.

Indexed as

Coronavirus M ProteinsA549 CellsAnimalsDogsHumansMadin Darby Canine Kidney CellsMiddle East Respiratory Syndrome CoronavirusMurine hepatitis virusMyosinsPorcine epidemic diarrhea virusrab GTP-Binding ProteinsSaccharomyces cerevisiaeSARS-CoV-2SwineViral Matrix ProteinsCoronavirus M ProteinsMyosinsRab10 protein, humanRab10 protein, mouserab GTP-Binding ProteinsViral Matrix Proteinscoronavirusmembrane recyclingMHVM proteinMYO5BMyosin VbRab10Rab11a

Identifiers

PMID38247817
PMCPMC10814003
OpenAlexW4390695998

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.